Skip to content

Application of a small molecule inhibitor screen approach

There is increasing evidence of the role it plays in CRC

Posted on October 28, 2024 by Courtney Roberts

There is increasing evidence of the role it plays in CRC. Some colonic tumors synthesise and release NT, resulting in autocrine control and cellular proliferation [91]. diagnosis, treatment, and follow-up of these patients. The aim of this review is to provide an overview of the newer Rabbit polyclonal to ZNF268 Continue Reading

Posted In DPP-IV

Categories

  • Activator Protein-1
  • Adenosine A3 Receptors
  • Adenosine, Other
  • AMPA Receptors
  • Amylin Receptors
  • Amyloid Precursor Protein
  • Angiotensin AT2 Receptors
  • AT Receptors, Non-Selective
  • CaM Kinase Kinase
  • Carbohydrate Metabolism
  • Catechol O-methyltransferase
  • COMT
  • DNA, RNA and Protein Synthesis
  • Dopamine Transporters
  • Dopaminergic-Related
  • DPP-IV
  • Endopeptidase 24.15
  • Exocytosis
  • F-Type ATPase
  • FAK
  • GLP2 Receptors
  • H2 Receptors
  • H4 Receptors
  • I??B Kinase
  • I1 Receptors
  • Inositol Monophosphatase
  • Isomerases
  • Leukotriene and Related Receptors
  • mGlu Group I Receptors
  • Mre11-Rad50-Nbs1
  • MRN Exonuclease
  • Muscarinic (M5) Receptors
  • N-Methyl-D-Aspartate Receptors
  • Neuropeptide FF/AF Receptors
  • NO Donors / Precursors
  • Other Proteases
  • Other Reductases
  • PKA
  • Platelet Derived Growth Factor Receptors
  • Polyamine Synthase
  • Protease-Activated Receptors
  • PrP-Res
  • Reagents
  • Reductase, 5??-
  • Selectins
  • Serotonin (5-HT1) Receptors
  • Tau
  • trpml
  • Tryptophan Hydroxylase
  • Urokinase-type Plasminogen Activator

Recent Posts

  • In 2007, Racil et approach
  • These glycosylases excise a broken base producing an abasic site that is converted to a single nucleotide space by AP endonuclease
  • L
  • Yet , vaccines ought to be reformulated annually owing to the rapid virus-like antigenic progress (Plotkin tout autant que al
  • The final decade indicates that there is a previously unrecognized variability among BoNT molecules: the serotypes A, M, E, and F can be distinguished into more than forty five subtypes based on their alanine sequence, antibody binding and functional activity
Copyright All rights reserved. Theme: Flash Blog by Unitedtheme.